NASDAQ:EYES Second Sight Medical Products (EYES) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$4.11▼$13.0552-Week Range N/AVolume36,800 shsAverage Volume132,982 shsMarket Capitalization$54.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Second Sight Medical Products alerts: Email Address Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> About Second Sight Medical Products Stock (NASDAQ:EYES)Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.Read More Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> EYES Stock News HeadlinesJuly 24 at 1:08 PM | businessinsider.comThe Best Credit Cards With Travel Insurance in 2024July 21, 2024 | msn.comSGLT-2 Inhibitors Top Other Diabetes Medications for Eye SafetyJuly 27, 2024 | True Market Insiders (Ad)Amazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…July 21, 2024 | dailymail.co.ukRisks of popular laser eye surgery may be MUCH higher than clinics claim: Special investigation finds procedure is linked to permanent scarring, agonising pain and even suicideApril 30, 2024 | yahoo.comneuroClues wants to put high speed eye tracking tech in the doctor's officeApril 23, 2024 | msn.comRestoring sight is possible now with optogeneticsApril 12, 2024 | msn.comI’m Trying the Sarah Hyland-Approved Under-Eye Patches That Reviewers Say Work ‘Miracles’March 16, 2024 | msn.comScary but Normal Baby Problems and How to Solve ThemJuly 27, 2024 | True Market Insiders (Ad)Amazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…March 16, 2024 | yahoo.comAn Optometrist Shared The One Eye Product We Should All Stop UsingMarch 15, 2024 | msn.comAnother dangerous amoeba has been linked to neti pots, nasal rinsing: What to knowMarch 14, 2024 | msn.comViking Soul Food Will Close Its Stalwart Belmont Street Food CartMarch 14, 2024 | yahoo.comExperts recommend eye safety during eclipseMarch 13, 2024 | msn.comAnother dangerous amoeba has been linked to neti pots and nasal rinsing. Here’s what to knowFebruary 18, 2024 | msn.comDandelions and shrubs to replace rubber, new grains and more: Are alternative crops realistic?February 2, 2024 | msn.comFDA warns of ‘copycat’ eye drops that can cause eye infectionFebruary 1, 2024 | msn.comHow to Stop Skin Picking for Even Just a SecondJanuary 4, 2024 | msn.comAll eyes are on glaucoma, the ‘silent thief of sight’ — and the truth behind 7 mythsSee More Headlines Receive EYES Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Second Sight Medical Products and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings6/29/2020Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical Equipment Sub-IndustryN/A Current SymbolNASDAQ:EYES CUSIPN/A CIK1266806 Webwww.secondsight.com Phone(818) 833-5000Fax818-833-5067Employees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,920,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-13.58% Return on Assets-13.02% Debt Debt-to-Equity RatioN/A Current Ratio22.15 Quick Ratio22.15 Sales & Book Value Annual Sales$3.38 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$4.80 per share Price / BookN/AMiscellaneous Outstanding Shares13,135,000Free Float6,935,000Market Cap$54.38 million OptionableOptionable Beta2.55 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Scott Dunbar (Age 64)Acting Chief Exec. Officer Comp: $301.39kMr. Edward Jonathon Sedo (Age 66)Acting Chief Accounting Officer, Principal Financial Officer & Controller Comp: $199.18kMr. Edward David Randolph (Age 64)Chief Operating Officer Comp: $366.44kGunnar BjorgFounderMs. Lisa M. Wilson (Age 57)Founder & Pres of In-Site Communications and Investor Relations for Second Sight Key CompetitorsNuwellisNASDAQ:CHFSOutset MedicalNASDAQ:OMEdap TmsNASDAQ:EDAPElectromedNYSE:ELMDFONARNASDAQ:FONRView All Competitors EYES Stock Analysis - Frequently Asked Questions How were Second Sight Medical Products' earnings last quarter? Second Sight Medical Products, Inc. (NASDAQ:EYES) posted its quarterly earnings results on Monday, June, 29th. The medical device company reported ($1.71) earnings per share for the quarter, missing the consensus estimate of ($1.23) by $0.48. When did Second Sight Medical Products' stock split? Shares of Second Sight Medical Products reverse split before market open on Friday, August 19th 2022. The 1-3 reverse split was announced on Friday, August 19th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. What is Will McGuire's approval rating as Second Sight Medical Products' CEO? 5 employees have rated Second Sight Medical Products Chief Executive Officer Will McGuire on Glassdoor.com. Will McGuire has an approval rating of 57% among the company's employees. This puts Will McGuire in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. When did Second Sight Medical Products IPO? Second Sight Medical Products (EYES) raised $32 million in an IPO on Wednesday, November 19th 2014. The company issued 3,500,000 shares at $9.00 per share. MDB Capital Group, LLC served as the underwriter for the IPO. What other stocks do shareholders of Second Sight Medical Products own? Based on aggregate information from My MarketBeat watchlists, some other companies that Second Sight Medical Products investors own include Zynerba Pharmaceuticals (ZYNE), Adaptimmune Therapeutics (ADAP), Cara Therapeutics (CARA), VBI Vaccines (VBIV), Shopify (SHOP), Corbus Pharmaceuticals (CRBP) and Sorrento Therapeutics (SRNE). This page (NASDAQ:EYES) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research.....The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Second Sight Medical Products, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Second Sight Medical Products With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.